JPRN-UMIN000013387暂停2 期
A phase II study comparing carboplatin plus pemetrexed followed by maintenance pemetrexed with pemetrexed in elderly patients with advanced epidermal growth factor receptor non-squamous non-small-cell lung cancer (LCEN1301) - A phase II study comparing CBDCA plus PEM followed by maintenance PEM with PEM in elderly patients with advanced EGFR wild type non-sq NSCLC (LCEN1301)
ung Cancer Experts Network (LCEN)0 个研究点目标入组 76 人开始时间: 2014年3月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Pulmonary fibrosis and interstitial pneumonia on chest X-ray or symptomatic pulmonary fibrosis and interstitial pneumonia 2) SVC synd 3) Uncontrolled diabetes, myocardial infarction or cerebral infarction within the past 3 months 4) Infectious disease requiring systemic treatment 5) Psychotic disorder 6) Synchronous or metachronous active double malignancies 7) History of allergic reaction for agents of present treatment 8) Severe heart disease 9) Patients with immunotherapy or vaccine therapy 10) Other ineligible status judged by medical oncologist
研究者
相似试验
已完成
2 期
A Multicenter phase II study of Carboplatin/Pemetrexed/Bevacizumab in First-Line Treatment of Elderly Patients with Advanced Non-squamous and Non-small Cell Lung canceron-squamous non-small cell lung cancerJPRN-UMIN000011095Kurume University School of Medicine42
已完成
3 期
A phase III study comparing carboplatin plus pemetrexed followed by maintenance pemetrexed with docetaxel in elderly patients with advanced non-squamous non-small-cell lung cancer (JCOG1210/WJOG7813L CBDCA/PEM vs DOC Phase III)Elderly patients with advanced non-squamous non-small-cell lung cancerJPRN-UMIN000011460Japan Clinical Oncology Group (JCOG)430
已完成
2 期
Phase II study of carboplatin and pemetrexed plus bevacizumab after failure of first-line EGFR TKI therapy for non-small-cell lung cancer harboring EGFR mutation.on-squamous Non-small-cell Lung CancerJPRN-UMIN000004731Central Japan Lung Study Group27
已完成
2 期
A phase II study of carboplatin plus pemetrexed followed by gefitinib for stage IIIB/IV non-small cell lung cancer with EGFR mutationon-small cell lung cancer with EGFR mutationJPRN-UMIN000003354Kanagawa Cancer Center60
进行中（未招募）
不适用
Phase II Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer - NDEUCTR2007-000913-13-ITELI LILLY47